JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tongsong, T.
Right arrow Articles by Luewan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tongsong, T.
Right arrow Articles by Luewan, S.
© 2009 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 28:13-18 • 0278-4297

High Fetal Splenic Artery Peak Velocity in Fetuses With Hemoglobin Bart Disease

A Preliminary Study

Theera Tongsong, MD, Fuanglada Tongprasert, MD, Kasemsri Srisupundit, MD and Suchaya Luewan, MD

Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Address correspondence to Theera Tongsong, MD, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., E-mail: ttongson{at}mail.med.cmu.ac.th

Objective. The purpose of this study was to evaluate the role of the splenic artery (SPA) peak systolic velocity (PSV) in identifying fetuses with hemoglobin (Hb) Bart disease among pregnancies at risk for the disease. Methods. Pregnancies at risk for fetal Hb Bart disease scheduled for cordocentesis at 18 to 25 weeks’ gestation at Maharaj Nakorn Chiang Mai Hospital were recruited into the study. The SPA PSV was measured before cordocentesis, and the final fetal diagnosis of Hb Bart disease was based on fetal Hb typing using high-performance liquid chromatography. Results. Seventy-six singleton pregnancies at risk for fetal Hb Bart disease were sonographically evaluated for the SPA PSV and underwent cordocentesis for fetal blood analysis. Among the 76 recruited pregnancies, 17 fetuses with Hb Bart disease were finally diagnosed by fetal blood analysis with high-performance liquid chromatography, and the remainder had no abnormalities or had the {alpha}-thalassemia 1 trait and were defined as unaffected fetuses. The mean SPA PSVs ± SD for the unaffected and affected fetuses were significantly different: 21.17 ± 3.7 cm/s (range, 13.8–29.9 cm/s) and 26.12 ± 3.6 cm/s (range, 20.4–31.5 cm/s) respectively. The SPA PSV of the affected fetuses was higher than that of the unaffected ones (Wilcoxon signed rank test, P < .001). Conclusions. Splenic artery PSV assessment at mid pregnancy may have a potential role in identifying fetuses with Hb Bart disease. Further studies to evaluate the effectiveness of the SPA PSV in differentiating affected from unaffected fetuses among pregnancies at risk are desirable.

Key Words: Doppler sonography • hemoglobin Bart disease • splenic artery peak systolic velocity

Abbreviations: Hb, hemoglobin • PSV, peak systolic velocity • SPA, splenic artery

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Institute of Ultrasound in Medicine.